$LEG

LEGGETT & PLATT INC

0
4
0

No SEC Form 4 filings for $LEG in the last 30 days.

Med

Leggett & Platt’s (NYSE:LEG) Q2 CY2026 Sales Top Estimates But Stock Drops

Leggett & Platt (NYSE:LEG) reported Q2 CY2026 revenue of $999.7 million, down 5.5% year on year but above analysts’ $982.9 million estimate. Non-GAAP EPS was $0.39 versus $0.26 expected. Free cash flow margin fell to 2.5% from 7.1% a year earlier. Shares dropped 5.1% to $9.73 after results.

Leggett & Platt Q2 Net Income Declines

Leggett & Platt (LEG) reported Q2 net income attributable to the company fell to $47.1 million from $52.5 million. EPS was $0.33 versus $0.38 a year earlier. Adjusted EBIT rose to $89 million from $76 million, aided by metal margin expansion and restructuring benefits. Sales were $1.0 billion, down 6% YoY, with organic sales down 1%. The company said its planned merger with Somnigroup is expected to close after remaining conditions, including shareholder approval on Aug. 20.

Leggett & Platt Reports 2Q 2026 Results

Leggett & Platt (NYSE: LEG) reported 2Q 2026 sales of $1.0 billion, down 6% year over year, with 2Q EPS of $0.33 and adjusted EPS of $0.39. Adjusted EBIT rose to $89 million. The company cited weak bedding and consumer demand and said HSR waiting expired for its planned merger with Somnigroup (NYSE: SGI), pending shareholder and regulatory approvals.

LEG sentiment & insider activity

Over the past 7 days, alphai's AI scored 4 news stories mentioning LEG (LEGGETT & PLATT INC). Coverage has been balanced: 0 bullish, 4 neutral, and 0 bearish.

Recent LEG coverage spans earnings, financial news and corporate actions.

What's driving LEG

  • Beat on EPS and revenue, but weaker cash generation and ongoing demand softness likely drove the selloff.

    yahoo.com · Aug 6, 2026

  • Lower reported earnings and declining sales are partially offset by higher adjusted EBIT, while merger progress adds a separate catalyst.

    rttnews.com · Aug 6, 2026

  • Results show margin/EPS improvement on an adjusted basis despite weaker volume, while the pending Somnigroup merger remains a key overhang into the Aug. 20 vote.

    prnewswire.com · Aug 6, 2026

  • Near-term trading focus is on whether margin and adjusted EPS strength offsets volume weakness, while the Somnigroup merger remains a key catalyst into the Aug. 20 shareholder vote.

    SEC EDGAR 8-K · Aug 6, 2026

  • LEG’s earnings miss on both revenue and EPS increases the probability of further estimate cuts and continued weakness.

    yahoo.com · Jul 22, 2026

alphai scores every news story that mentions LEG with an AI model for sentiment and relevance, and aggregates insider trades from LEGGETT & PLATT INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $LEG

Score
$LEGMed

Leggett & Platt Q2 Net Income Declines

Leggett & Platt (LEG) reported Q2 net income attributable to the company fell to $47.1 million from $52.5 million. EPS was $0.33 versus $0.38 a year earlier. Adjusted EBIT rose to $89 million from $76 million, aided by metal margin expansion and restructuring benefits. Sales were $1.0 billion, down 6% YoY, with organic sales down 1%. The company said its planned merger with Somnigroup is expected to close after remaining conditions, including shareholder approval on Aug. 20.

$LEGMedAI 8/10

Leggett & Platt Reports 2Q 2026 Results

Leggett & Platt (NYSE: LEG) reported 2Q 2026 sales of $1.0 billion, down 6% year over year, with 2Q EPS of $0.33 and adjusted EPS of $0.39. Adjusted EBIT rose to $89 million. The company cited weak bedding and consumer demand and said HSR waiting expired for its planned merger with Somnigroup (NYSE: SGI), pending shareholder and regulatory approvals.

LEGGETT & PLATT INC (LEG): Results of Operations and Financial Condition

LEGGETT & PLATT INC (LEG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d121836dex991.htm PRESS RELEASE DATED AUGUST 6, 2026 PRESS RELEASE DATED AUGUST 6, 2026 EXHIBIT 99.1 FOR IMMEDIATE RELEASE: August 6, 2026 Leggett & Platt Reports 2Q 2026 Results Carthage, MO, August 6, 2026 — • 2Q sales of $1.0 billion, a 6% decrease vs 2Q25, including

$PRPLMed

Q1 Earnings Roundup: Purple (NASDAQ:PRPL) And The Rest Of The Consumer Discretionary - Home Furnishings Segment

An earnings roundup for consumer discretionary home furnishings highlights Purple (PRPL) with results and full-year guidance viewed as weaker than analysts, with the stock down 60.3% to $6.40. Lovesac (LOVE) reported $138.2M revenue, flat YoY, beating by 1.2%, and shares up 6.4% to $17.54. Leggett & Platt (LEG) revenue $918.2M, down 10.2%, missed EPS. Mohawk (MHK) revenue $2.73B up 8%, slightly below estimates. Somnigroup (SGI) revenue $1.80B up 12.3%, below estimates.

$LEGLow

143-Year-Old Manufacturing Company Shutting Its Doors In Inland Empire

Leggett & Platt said, according to a California state filing, it will permanently close its Ontario, California plant by Aug. 14. The move follows weak residential demand and comes ahead of Somnigroup International’s planned all-stock acquisition of Leggett & Platt valued at about $2.5 billion, expected to close by year-end. Leggett & Platt previously announced restructuring, including plant closures and layoffs.

$LEGMed

Leggett & Platt stock (US5246601075): dividend under pressure after payout suspension and credit downgrade

Leggett & Platt has suspended its dividend and faced a credit rating downgrade to BB+ with a negative outlook, due to restructuring efforts and balance sheet concerns. The company, a major supplier in the US furnishings supply chain, is undergoing a strategic review to simplify its portfolio and reduce leverage. This shift impacts its investment profile, moving focus from dividend income to long-term balance sheet health and restructuring execution.

$LEGMed

Leggett & Platt (LEG) CFO receives stock grant and updates holdings

Leggett & Platt's Executive Vice President and CFO, Benjamin Michael Burns, received a stock award of 136.5034 shares of common stock valued at $8.2365 per share. This grant increased his direct holdings to 190,673.0931 shares and the filing also detailed his indirect holdings, including shares in retirement plans and those held by his spouse. The transactions were reported in an SEC Form 4 filing, indicating a compensation-related grant.

$LEGMed

Is Leggett & Platt, Incorporated (LEG) A Good Stock To Buy Now?

Shares of Leggett & Platt, Incorporated (LEG) are trading at a low valuation due to challenging market conditions in key end markets. The company, a diversified manufacturer, has attracted an unsolicited bid from Somnigroup (SGI) at $12 per share, with potential for a higher negotiated offer. This acquisition would offer significant vertical integration benefits and strategic advantages within the bedding industry, presenting a compelling risk/reward scenario for investors.

$LEGMed

Stock grant lifts Leggett & Platt (LEG) director shareholdings

Leggett & Platt (LEG) director Joseph W. McClanathan received a stock grant of 13,674 shares of common stock, valued at $0.00 per share, as equity-based compensation. This transaction increased his direct holdings to 119,566.8157 shares. The grant aligns the director's financial interests with the company's share performance and was filed as a Form 4.

Related tickers